A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease
Clinical trial NCT02513459 · COMPLETED
Trial details
- NCT number
- NCT02513459
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-16
- Primary completion
- 2019-06-19
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.